Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neema Navai

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
European Urology Focus|July 30, 2017
Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical CystectomyJanet Baack Kukreja, Sima Porten, Vishnukamal Golla, et al.
European Urology Oncology|June 16, 2019
Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not BenignRoger Li, Michael J Metcalfe, William B Tabayoyong, et al.
Urologic Oncology|December 14, 2020
Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost driversJanet Baack Kukreja, Mohamed A Seif, Marissa W Mery, et al.
The Journal of Urology|January 27, 2021
Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial DesignJustin T Matulay, Roger Li, Patrick J Hensley, et al.
The Journal of Urology|October 17, 2022
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not TherapeuticKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|May 22, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. ReplyKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|March 18, 2021
Reply by AuthorsJustin T Matulay, Roger Li, Patrick J Hensley, et al.
The Journal of Sexual Medicine|July 28, 2020
Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional AnalysisMary E Westerman, Andrea Kokorovic, Xin Shelly Wang, et al.
European Urology Oncology|August 9, 2023
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical CystectomyRoberto Contieri, Patrick J Hensley, Wei Shen Tan, et al.
BJU International|March 30, 2021
Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic responsePatrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
European Urology Focus|July 30, 2017
Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical CystectomyJanet Baack Kukreja, Sima Porten, Vishnukamal Golla, et al.
European Urology Oncology|June 16, 2019
Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not BenignRoger Li, Michael J Metcalfe, William B Tabayoyong, et al.
Urologic Oncology|December 14, 2020
Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost driversJanet Baack Kukreja, Mohamed A Seif, Marissa W Mery, et al.
The Journal of Urology|January 27, 2021
Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial DesignJustin T Matulay, Roger Li, Patrick J Hensley, et al.
The Journal of Urology|October 17, 2022
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy is Prognostic but Not TherapeuticKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|May 22, 2023
Repeat Transurethral Resection of Muscle-invasive Bladder Cancer Prior to Radical Cystectomy Is Prognostic but Not Therapeutic. ReplyKelly K Bree, Andrea Kokorovic, Mary E Westerman, et al.
The Journal of Urology|March 18, 2021
Reply by AuthorsJustin T Matulay, Roger Li, Patrick J Hensley, et al.
The Journal of Sexual Medicine|July 28, 2020
Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional AnalysisMary E Westerman, Andrea Kokorovic, Xin Shelly Wang, et al.
European Urology Oncology|August 9, 2023
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical CystectomyRoberto Contieri, Patrick J Hensley, Wei Shen Tan, et al.
BJU International|March 30, 2021
Time interval from transurethral resection of bladder tumour to bacille Calmette-Guérin induction does not impact therapeutic responsePatrick J Hensley, Kelly K Bree, Nathan Brooks, et al.
Pageof 11